首页> 外文期刊>Bioconjugate Chemistry >Diphtheria Toxin-Epidermal Growth Factor Fusion Protein and Pseudomonas Exotoxin-Interleukin 13 Fusion protein Exert synergistic Toxicity against human Glioblastoma multiforme cells
【24h】

Diphtheria Toxin-Epidermal Growth Factor Fusion Protein and Pseudomonas Exotoxin-Interleukin 13 Fusion protein Exert synergistic Toxicity against human Glioblastoma multiforme cells

机译:白喉毒素-表皮生长因子融合蛋白和假单胞菌外毒素-白介素13融合蛋白对人成胶质细胞瘤多形细胞具有协同毒性

获取原文
获取原文并翻译 | 示例
           

摘要

The cytotoxicity of combinations of a diphtheria toxin-human epidermal growth factor fusion protein (DAB_389EGF)and a Pseudomonas exotoxin-human interleukin 13 fusion protein (IL13PE38QQR)was tested against 14 human glioma cell lines.After cells were cultured for 48 h with various concentrations of the fusion proteins,the percentage reductions in thymidine incorporation were determined.Seven of fourteen cell lines were highly sensitive to DAB_389EGF alone,and six cell lines were highly sensitive to IL13PE38QQR alone with IC_90's<100 pM.When combined,synergistic cel killing was observed for seven of hte cell lines based upon concave isobolograms and combination indices (CI's)of 0.2 to 0.7.Supraadditive cytotoxicitky was confirmed by measurements of induction of apoptosis.Receptor expression was assessed by flow cytometry ad confocal microscopy.Marked heterogeneity may contribute to incomplete cell lilling with the individual fusion proteins and synergistic cell kill with the combination.These results suggest that both fusion proteins may yield antitumor effects in partients with recurrent gliomas and that combinatin fusion protein intracranial therapy of malignant gliomas may yield an improved therapeutic index.
机译:测试了白喉毒素-人表皮生长因子融合蛋白(DAB_389EGF)和假单胞菌外毒素-人白介素13融合蛋白(IL13PE38QQR)组合对14种人脑胶质瘤细胞系的细胞毒性。不同浓度的细胞培养48小时后对14个细胞系中的7个对单独的DAB_389EGF高度敏感,对6个细胞系对单独的IL13PE38QQR高度敏感,IC_90's <100 pM。合并后,观察到协同的细胞杀伤作用根据凹等剂量线图和0.2至0.7的组合指数(CI)对7种hte细胞系进行了检测,通过诱导凋亡的方法确定了超加性细胞毒性,并通过共聚焦显微镜通过流式细胞术评估了受体的表达,标记的异质性可能导致不完整的细胞结合在一起导致单个融合蛋白和协同细胞杀伤这些结果表明,两种融合蛋白均可能对复发性神经胶质瘤患者产生抗肿瘤作用,而组合素融合蛋白颅内治疗恶性神经胶质瘤可能产生更高的治疗指数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号